ArticleDrug design, development and therapy2022

Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway.

Hongchun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.